Charles Bonnet syndrome: two case reports and review of the literature

被引:19
|
作者
Lerario, Alberto [1 ,2 ,3 ]
Ciammola, Andrea [1 ,2 ]
Poletti, Barbara [1 ,2 ]
Girotti, Floriano [1 ,2 ]
Silani, Vincenzo [1 ,2 ,3 ]
机构
[1] IRCCS Ist Auxol Italiano, Dept Neurol, I-20149 Milan, Italy
[2] IRCCS Ist Auxol Italiano, Neurosci Lab, I-20149 Milan, Italy
[3] Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, Dino Ferrari Ctr, I-20145 Milan, Italy
关键词
Visual hallucinations; Age related macular degenerations; Eye diseases; Visual pathway; Visual loss; Extrapyramidal syndromes; COMPLEX VISUAL HALLUCINATIONS; OCCIPITAL CORTICAL RESECTION; MACULAR DEGENERATION; BONNET; CHARLES SYNDROME; SENSORY DEPRIVATION; MULTIPLE-SCLEROSIS; HEMIANOPIC FIELD; VISION LOSS; BONNETSYNDROME; CHARLES; INFARCTION;
D O I
10.1007/s00415-013-6857-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Visual hallucinations (VHs) can be associated with a variety of clinical conditions, and are also experienced by healthy people due to visual impairment. The condition is known as Charles Bonnet Syndrome (CBS). The circumstances favoring VHs support the hypothesis that sensory deprivation enhances the ongoing activity of the visual system after sensory loss. Clinician should be aware that a significant proportion of visually impaired patients experience complex VHs, which are sometimes distressing. Herein, we report two cases of CBS. Case 1 is a 60-year-old man with visual impairment due to orbit pseudotumor in autoimmune hypothyroidism. Case 2 is an 87-year-old woman with Parkinson's disease and a 15-year history of intermittent complex VHs due to age-related macular degeneration in both eyes. In both cases investigations for alternative pathological causes of VHs were negative and, therefore, the aetiology of hallucinations was attributed to CBS. The course and treatment of CBS patients vary according to the nature of the visual dysfunction. Drug treatments remain partially satisfactory, with individual cases successfully treated with atypical antipsychotics. Nonpharmacological interventions aimed to reduce the visual pathway deprivation. Reassurance of the benign nature of CBS is essential to support patients and reduce caregiver's burden.
引用
收藏
页码:1180 / 1186
页数:7
相关论文
共 50 条
  • [1] Charles Bonnet syndrome: two case reports and review of the literature
    Alberto Lerario
    Andrea Ciammola
    Barbara Poletti
    Floriano Girotti
    Vincenzo Silani
    Journal of Neurology, 2013, 260 : 1180 - 1186
  • [2] Charles Bonnet syndrome: Two case reports
    Gupta, Ravi
    Sinchal, Anil
    Goel, Deepak
    Srivastava, Rajendra
    Mittal, Sunil
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2008, 20 (03) : 377 - 378
  • [3] Charles Bonnet Syndrome A Case Report and Review of the Literature
    Mansuri, Zeeshan
    Patel, Krupa
    Shah, Bhumika
    Trivedi, Chintan
    Adnan, Mahwish
    Vadukapuram, Ramu
    Zafar, Muhammad Khalid
    Makani, Ramkrishna
    Reddy, Abhishek
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2022, 210 (11) : 880 - 882
  • [4] Charles Bonnet syndrome: a case report and review of the literature
    Lerario, A.
    Altieri, A.
    Ciammola, A.
    Silani, V.
    JOURNAL OF NEUROLOGY, 2012, 259 : S100 - S101
  • [5] Charles Bonnet syndrome: Case presentation and Literature review
    Kester, Elizabeth M.
    OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION, 2009, 80 (07) : 360 - 366
  • [6] Charles Bonnet Syndrome: A Review of the Literature
    O' Farrell, Lauren
    Lewis, Sandra
    McKenzie, Amy
    Jones, Lynda
    JOURNAL OF VISUAL IMPAIRMENT & BLINDNESS, 2010, 104 (05) : 261 - 274
  • [7] Management of Charles Bonnet Syndrome: A Review of the Literature
    Dahl, Jacqueline T.
    Guerrieri, Gioia M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (03): : S78 - S78
  • [8] Prevalence of the Charles Bonnet Syndrome – a review of the literature
    Döller B.
    Findl O.
    Spektrum der Augenheilkunde, 2017, 31 (1) : 2 - 5
  • [9] Charles Bonnet syndrome during mourning: Case analysis with literature review
    Kaufman, K.
    Aaron, R.
    Prager, A.
    Lepore, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S218 - S218